Senior insider sale
Chief Science Officer at NOVOCURE LTD — senior position signals high conviction
$146.9K
10.73K shares
What this filing means
WEINBERG URI plans to sell 10.73K shares of NOVOCURE LTD valued at approximately $146.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/2/2026ACC: 0001950047-26-001960
Officer· Chief Science Officer
Since Apr 2020
10.73K
Shares to sell
$146.9K
Approx. market value
3.27K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months2
Restricted Stock
Not Applicable
2/28/2026
818.00Performance Shares
Not Applicable
2/28/2026
2.45KTotal acquired3.27K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/28/2026 | Restricted Stock Not Applicable | 818.00 | — |
2/28/2026 | Performance Shares Not Applicable | 2.45K | — |
| Total | 3.27K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
7.46K
Market value
$103.3K
2/27/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
3.27K
Market value
$43.6K
3/2/2026
Total
Units
10.73K
Value
$146.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/27/2026 | 7.46K | $103.3K | — | Completed |
| Planned — Approximate Date | ||||
3/2/2026 | 3.27K | $43.6K | NASDAQ | Planned |
| Total | 10.73K | $146.9K | ||